BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia

Blood

Volumn 88, Issue 5, 1996, Pages 1796-1804

  Maguer Satta, Veronique ^b   Petzer, Andreas L ^b   Eaves, Allen C ^b   Eaves, Connie J ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BCR ABL PROTEIN; CD34 ANTIGEN; GENE PRODUCT; MESSENGER RNA;

ADULT; ARTICLE; CELL STRAIN K 562; CELL SUBPOPULATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029836465     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1796.1796     Document Type: Article

References (52)

1. Goldman JM (ed): Chronic Myeloid Leukaemia. London, UK, Bailliere Tindall, 1987
2. Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D: The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science 233:212, 1986
3. Konopka JB, Watanabe SM, Witte ON: An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035, 1984
4. Van Etten RA, Jackson P, Baltimore D: The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669, 1989
5. Wetzler M, Talpaz M, Van Etten RA, Hirsch-Ginsberg C, Beran M, Kurzrock R: Subcellular localization of BCR, ABL and BCR-ABL proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J Clin Invest 92:1925, 1993
6. Daley GQ, Ben-Neriah Y: Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia. Adv Cancer Res 57:151, 1991
7. Druker B, Okuda K, Matulonis U, Salgia R, Roberts T, Griffin JD: Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines. Blood 79:2215, 1992
8. Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T: Bcr-Abl oncoproteins bind directly to activators of the ras signalling pathway. EMBO J 13:764, 1994
9. BCR-AHI. tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene 9:149, 1994
10. + leukemia. Blood 84:1731, 1994
11. Nichols GL, Raines MA, Vera JC, Lacomis L, Tempst P, Golde DW: Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Blood 84:2912, 1994
12. Raskind WH, Fialkow PJ: The use of cell markers in the study of human hematopoietic neoplasia. Adv Cancer Res 49:127, 1987
13. Singer JW, Fialkow PJ, Steinmann L, Najfeld V, Stein SJ, Robinson WA: Chronic myelocytic leukemia (CML): Failure to detect residual normal committed stem cells in vitro. Blood 53:264, 1979
14. Kalousek DK, Eaves CJ, Eaves AC: In-vitro cytogenetic studies of haemopoietic malignancies. Cancer Surv 3:439, 1984
15. Eaves C, Eaves A: Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro. Blood Cells 20:83, 1994
16. Ponchio L, Cashman J, Zoumbos N, Eaves CJ, Eaves A: Primitive CML cells show a deregulation of their cycling status both in vivo and in longterm cultures which is not normalized in the presence of interferon-α. Blood 86:493a, 1995 (abstr, suppl 1)
17. Verfaillie CM, McCarthy JB, McGlave PB: Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. J Clin Invest 90:1232, 1992
18. Udomsakdi C, Eaves CJ, Swolin B, Reid DS, Barnett MJ, Eaves AC: Rapid decline of chronic myeloid leukemic cells in longterm culture due to a defect at the leukemic stem cell level. Proc Natl Acad Sci USA 89:6192, 1992
19. Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A: The biology of normal and neoplastic stem cells in CML. Leuk Lymphoma 11:245, 1993 (abstr, suppl 1)
20. + chronic myelogenous leukemia and effects of intensive treatment. Blood 59:793, 1982
21. Talpaz M, Kantarjian HM, McCredie KB, Keating MJ, Trujillo J, Gutterman J: Clinical investigation of human alpha interferon in chronic myelogenous leukemia. Blood 69:1280, 1987
22. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU: Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. Ann Intern Med 114:532, 1991
23. Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, Dick JE: Normal and leukemic SCID-repopulating cells (SRC) co-exist in the bone marrow and peripheral blood from CML patients in chronic phase while leukemic SRC are detected in blast crisis. Blood 87:1539, 1996
24. Bedi A, Zehnbauer BA, Collector MI, Barber JP, Zicha MS, Sharkis SJ, Jones RJ: BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood 81:2898, 1993
25. + cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood 83:1744, 1994
26. Keating A, Wang XH, Laraya P: a-interferon suppresses transcription of BCR-ABL in Ph+ chronic myeloid leukemia (CML) progenitor cells. Exp Hematol 21:1073, 1993
27. Szczylik C, Skorski T, Nicolaides NC, Manzella L, Malaguarnera L, Venturelli D, Gewirtz AM, Calabretta B: Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science 253:562, 1991
28. de Fabritis P, Amadori S, Petti MC, Mancini M, Montefusco E, Picardi A, Geiser T, Campbell K, Calabretta B, Mandelli F: In vitro purging with BCR-ABL antisense oligodeoxynucleotides does not prevent haematologic reconstitution after autologous bone marrow transplantation. Leukemia 9:662, 1995
29. Leopold LH, Shore SK, Newkirk TA, Reddy RM, Reddy EP: Multi-unit ribozyme-mediated cleavage of BCR-ABL mRNA in myeloid leukemias. Blood 85:2162, 1995
30. Petzer AL, Lansdorp PM, Shaw GJ, Barnett MJ, Eaves AC, Eaves CJ: Elevated numbers of CD38-, Thy-1 + LTC-IC are present in the blood of newly diagnosed CML patients and include both Ph-and Ph+ genotypes. Exp Hematol 23:791, 1995 (suppl 8)
31. Collins SJ, Groudine MT: Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proc Natl Acad Sci USA 80:4813, 1983
32. Collins SJ, Gallo RC, Gallagher RE: Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347, 1977
33. Craig W, Kay R, Cutler RL. Lansdorp PM: Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 177:1331, 1993
34. Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ: Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87:3584, 1990
35. Hogge D, Reid D, Gerhard B, Lansdorp P, Eaves C: Murine fibroblasts producing human steel factor (SF), IL-3 and G-CSF can enhance the maintenance of human longterm culture-initiating cells (LTC-IC) and their output of clonogenic cells (CFC). Blood 86:493a, 1995 (abstr, suppl 1)
36. Fraser C, Eaves CJ, Kalousek DK: Fluorodeoxyuridine synchronization of hemopoietic colonies. Cancer Genet Cytogenet 24:1, 1987
37. + subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 91:12223, 1994
38. Sugimoto T, Fujita M, Taguchi T, Mortita T: Quantitative detection of DNA by co-amplification polymerase chain reaction: A wide detectable range controlled by thermodynamic stability of primer template duplexes. Anal Biochem 222:170, 1993
39. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996
40. Lugo TG, Pendergast AM, Muller AJ, Witte ON: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079, 1990
41. Cortez D, Kadlec L, Pendergast AM: Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol Cell Biol 15:5531, 1995
42. Goga A, McLaughlin J, Afar DEH, Saffran DC, Witte ON: Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell 82:981, 1995
43. Evans CA, Owen-Lynch J, Whetton AD, Dive C: Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. Cancer Res 53:1735, 1993
44. Voncken JW, Morris C, Pattengale P, Dennert G, Kikly C, Groffen J, Heisterkamp N: Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice. Blood 79:1029, 1992
45. Verfaillie CM, Miller WJ, Boylan K, McGlave PB: Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003, 1992
46. Leemhuis T, Leibowitz D, Cox G, Silver R, Srour EF, Tricot G, Hoffman R: Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood 81:801, 1993
47. lo population but not in the CD34+/CD38k> population in chronic myeloid leukemia: An analysis using interphase fluorescence in situ hybridization. Blood 86:737, 1995
48. Tkachuk DC, Westbrook CA, Andreefe M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D: Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science 250:559, 1990
49. Bedi A, Zehnbauer BA, Barber J, Sharkis S, Jones R: Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83:2038, 1994
50. Wognum AW, Krystal G, Eaves CJ, Eaves AC, Lansdorp PM: Increased erythropoietin-receptor expression on CD34-positive bone marrow cells from patients with chronic myeloid leukemia. Blood 79:642, 1992
51. Ghaffari S, Dougherty GJ, Lansdorp PM, Eaves AC, Eaves CJ: Differentiation - associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 86:2976, 1995
52. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF: Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328:342, 1987